Metformin to Reduce Airway Glucose in COPD Patients

NCT03651895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

Imperial College London